Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - COMMON STOCK
Common Stock ESPR - Esperion Therapeutics, Inc.
118 K
LAST VALUE
39.08%
2 YEAR CAGR
34.31%
5 YEAR CAGR
22.62%
10 YEAR CAGR